Temperature Controlled Pharma Products Market| COVID-19 Analysis and Outlook
Market Research Future (MRFR), asserts that the global Temperature Controlled Pharma Products market is expected to exhibit a CAGR of 9.48% over the forecast period of 2018-2023 and value at USD 8,762.4 million by 2023. Primarily, the increase in number of thermal-sensitive drugs is gaining traction for the market. Industry News September 2019 Peli BioThermal, a leader in providing thermal-controlled packaging solutions, exhibited its solution at Defence and Security Equipment International (DSEI) 2019 for the first time. Segmental Overview The Temperature Controlled Pharma Products market is segmented by payload capacity, product, type of use, temperature range, type, and end-use industry. By product, the market is divided into insulated containers and insulated shippers. The insulated shippers segment is likely to lead in forecast period. By type, the market is segmented into passive systems and active systems. The active systems segment is expected to expand at a C...